Completed PHASE4 INTERVENTIONAL 2-arm NCT01976780

In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy

In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy in Kisumu County, Western Kenya

Sponsor: Global Emerging Infections Surveillance and Response System

Conditions Malaria

Interventions Artemether Lumefantrine Artesunate Mefloquine

Updated 5 times since 2017 Last updated: May 10, 2017 Started: Jun 30, 2013 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01976780, this PHASE4 trial focuses on Malaria and remains completed. Sponsored by Global Emerging Infections Surveillance and Response System, it has been updated 5 times since 2013, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Global Emerging Infections Surveillance and Response System
United States Army Medical Unit - Kenya
Walter Reed Army Institute of Research (WRAIR)

Data source: Global Emerging Infections Surveillance and Response System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kisumu, Kenya